Cybersecurity Audit vs Cybersecurity Assessment: A Compliance Guide for FDA & EU MDR Standards.

In today’s interconnected world, protecting your digital assets is no longer optional; it’s a business necessity. However, the jargon can be overwhelming. Two terms often used interchangeably but which serve very different purposes are Cybersecurity Audit and Cybersecurity Assessment.

In the medical device industry, security isn't just a technical goal; it's a legal requirement for market access. Here is the breakdown of the applicable standards for the US and EU markets as of 2026.

As an AI and cybersecurity consultancy, we frequently see organizations confuse these two. Understanding the difference is critical, especially for medical device manufacturers navigating the complex regulatory requirements of the FDA and the EU MDR.

Here is a simple breakdown to help you determine which one your organization needs and when.

Cybersecurity Audit vs. Assessment: Key Differences for MedTech.

Think of a Cybersecurity Assessment like a regular health check-up with your doctor. You do it to find out where you are vulnerable and how to get healthier.

Think of a Cybersecurity Audit like a final exam or a tax audit. It is a formal review to prove to an outside authority that you are following the rules.

Based on industry standards, here is how they compare:

Aspect	Cybersecurity Audit	Cybersecurity Assessment
Definition	A formal review to validate that security controls are present and functioning.	A comprehensive evaluation to identify specific risks and vulnerabilities.
Primary Focus	Compliance: Does the company meet the required standards and policies?	Effectiveness: How well are the controls working and where are the gaps?
Frequency	A "snapshot" or point-in-time review (e.g., once a year).	Continuous or real-time monitoring.
Who Does It?	Independent third parties or certified internal audit teams.	Internal teams or automated tools for ongoing analysis.
Cost	Generally higher due to specialized third-party labor.	Often more cost-effective through automation and scalability.
Main Benefit	Builds trust with partners and ensures you stay legal/certified.	Proactively identifies threats and supports continuous improvement.
Best Use Case	When you need to prove compliance to a regulator or vendor.	When you want to improve your actual security posture and fix bugs.

Source : The comparison table in this article is synthesized from general industry best practices in cybersecurity frameworks (such as NIST and ISO/IEC 27001) and reflects the core distinctions recognized by cybersecurity professionals globally.

Why This Matters for Medical Devices (FDA & EU MDR)

If you are developing medical technology(SiMD/SaMD) or AI-enabled medical products, these definitions take on a much higher level of importance. Regulators are no longer satisfied with "checked boxes"; they want to see active risk management.

1. FDA: The "Quality System" Perspective

The FDA views cybersecurity as an extension of the Quality Management System (QMS). To pass an FDA review, your documentation must show that security was "designed-in," not bolted on.

The Assessment Side (Proactive Risk Management)

The FDA expects a lifecycle-long risk management process. Key standards include:

ISO 14971:The gold standard for medical device risk management. It focuses on patient safety.
AAMI TIR57: Specifically bridges ISO 14971 (Safety) with Security. It provides the methodology to perform security risk management in the context of safety.
SW96 (ANSI/AAMI SW96:2023): A newer, formalized standard that provides specific requirements for security risk management throughout the product lifecycle.
NIST Cybersecurity Framework (CSF): Often used as the overarching organizational framework to identify, protect, detect, respond, and recover.

Source : : AAMI (Association for the Advancement of Medical Instrumentation) Standard for Medical Device Security.

The Audit Side (Regulatory Proof)

During pre-market (510(k), PMA) or post-market inspections, the FDA audits your adherence to:

Section 524B of the FD&C Act: This is the legal requirement that "cyber devices" must have a plan to monitor, identify, and address post-market vulnerabilities.
FDA Final Guidance (2026): “Cybersecurity in Medical Devices: Quality Management System Considerations.” This document outlines exactly what needs to be in your submission (e.g., Software Bill of Materials (SBOM), Threat Models).

The FDA "Cyber Device" Mandate (Section 524B)

As of early 2026, the FDA has fully operationalized Section 524B of the FD&C Act. This is no longer "suggested guidance"; it is a legal requirement.

Assessment Impact: Manufacturers must provide a Software Bill of Materials (SBOM) and have a coordinated vulnerability disclosure (CVD) process.
Audit Impact: Failure to provide these in a pre-market submission now results in a "Refuse to Accept" (RTA) decision.

Source : AAMI (Association for the Advancement of Medical Instrumentation) Standard for Medical Device Security.

2. EU MDR: Harmonized Standards

In the EU, compliance is driven by the General Safety and Performance Requirements (GSPR) found in Annex I of the MDR.

The Assessment Side

To meet the "state-of-the-art" requirement, manufacturers look to:

IEC 81001-5-1: This is the primary standard for "Health software and health IT systems." it defines the activities required in the product lifecycle to ensure security.
MDCG 2019-16: The essential guidance document from the Medical Device Coordination Group. It provides a roadmap for fulfilling the cybersecurity requirements of the MDR.
GDPR (General Data Protection Regulation): Specifically focusing on "Privacy by Design." While the user mentioned Article 17 (Right to Erasure), cybersecurity assessments must also ensure the technical measures for Article 32 (Security of Processing) are met.
NIST Cybersecurity Framework (CSF): Often used as the overarching organizational framework to identify, protect, detect, respond, and recover.

The Audit Side (Conformity Assessment)

Your Notified Body will audit your Technical Documentation against:

GSPR 17.2 & 17.4: These specific sections of Annex I require that devices featuring software be developed in accordance with the "state of the art," taking into account the principles of development lifecycle, risk management, and information security.
Post-Market Surveillance (PMS): The audit will check if your PMS plan (Articles 83-86) includes active vulnerability monitoring and a clear "vigilance" reporting path for cyber incidents.

Source : MDCG 2019-16 Rev. 1; IEC 81001-5-1:2021 (Health software and health IT systems).

The following "Summary of Applicable Standards" is curated from official FDA guidance, EU Medical Device Coordination Group (MDCG) documents, and international standardization bodies (AAMI, ISO, IEC).

Region	Regulatory Body	Key Assessment Standards (Risk Management)	Key Audit Standards (Quality & Compliance)
United States	FDA	ANSI/AAMI SW96:2023 (Security Risk Management); AAMI TIR57 (Safety/Security Integration); ISO 14971	Section 524B FD&C Act; FDA Final Guidance (Feb 2026): Cybersecurity in Medical Devices: Quality System Considerations
European Union	EMA / Notified Bodies	IEC 81001-5-1 (Security Activities in Product Lifecycle); MDCG 2019-16	EU MDR Annex I (GSPR 17.2, 17.4); ISO 13485 (QMS); GDPR Article 32 (Security of Processing)
Global	IMDRF	NIST Cybersecurity Framework (CSF); IEC 62304 (Software Lifecycle)	ISO/IEC 27001 (Information Security Management)

The Regulatory Imperative: Bridging the Gap Between Safety and Security

You cannot pass an audit without first performing an assessment.

If you only do Audits, you might be "compliant" on paper while still being vulnerable to a zero-day attack. You are looking in the rear view mirror.

If you only do Assessments, you might be very secure, but you will fail to get your product to market because you cannot provide the formal documentation required by the FDA or EU regulators.

Our Recommendation

For a digital health startup or an established med-tech firm, the goal should be Continuous Assessment (to stay secure) leading into Periodic Audits (to stay compliant).

Bridge the Gap Between Security and Regulatory Approval: Contact Our Expert Team Today

Contact our team bala@cdaqi.com for a consultation on how to align your AI and medical device cybersecurity legal requirements for market access.

Turnkey Services